JPH10298006A - Sterilization composition for industry and sterilization - Google Patents

Sterilization composition for industry and sterilization

Info

Publication number
JPH10298006A
JPH10298006A JP9121608A JP12160897A JPH10298006A JP H10298006 A JPH10298006 A JP H10298006A JP 9121608 A JP9121608 A JP 9121608A JP 12160897 A JP12160897 A JP 12160897A JP H10298006 A JPH10298006 A JP H10298006A
Authority
JP
Japan
Prior art keywords
weight
composition
component
halogen
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9121608A
Other languages
Japanese (ja)
Inventor
Hitoshi Egawa
均 江川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shinto Paint Co Ltd
Original Assignee
Shinto Paint Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinto Paint Co Ltd filed Critical Shinto Paint Co Ltd
Priority to JP9121608A priority Critical patent/JPH10298006A/en
Publication of JPH10298006A publication Critical patent/JPH10298006A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject composition having a strong sterilizing potency or bacteriostatic and fungistatic potencies and effective for a wide range of microorganisms by including a halocyanoacetamide compound, a halogenated acetate ester derivative, and a specific compound. SOLUTION: This composition comprises (A) a halocyanoacetamide compound of formula I (X is a halogen; Y is H, a halogen; R is H, a lower alkyl) (e.g. 2,2-dibromo-3-nitrilopropionamide), (B) a halogenated acetate ester derivative of formula II (Z is a halogen; A is an alkylene, an alkenylene) [e.g. 1,4-bis(bromoacetoxy)-2-butene], and (C) 4,5-dichloro-1,2-dithiol-3-one preferably in a weight ratio of 1:(0.1-10):(0.01-10). The composition is added to white water in a paper-making process, an aqueous composition for industry, etc., at a dose of 1-20000 ppm as the separated ingredients or as a formulated mixture.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、紙パルプ工業用分
野における抄紙工程中の細菌・真菌をはじめとする微生
物に由来するスライムの付着を防止するため、また塗
料、ラテックス、デンプンスラリー液紙用コーティング
カラー、洗浄水、冷却水、接着剤、金属加工油等の水を
ベースに作成されている工業用水系組成物が微生物汚染
による腐敗、変色、物性劣化を受けることを防止するた
めの抗菌組成物及び抗菌方法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a pulp and paper industry for preventing the adhesion of slime derived from microorganisms such as bacteria and fungi in the papermaking process, and for coating paper, latex and starch slurry. An antibacterial composition for preventing industrial water-based compositions made based on water such as coating colors, washing water, cooling water, adhesives, metalworking oils, etc. from undergoing spoilage, discoloration, and deterioration in physical properties due to microbial contamination. And antimicrobial methods.

【0002】[0002]

【従来の技術】紙パルプ工業分野における抄紙工程で
は、紙を生産するために大量の水を使用しており、その
水には紙を生産するために必要な各種有機物が分散・溶
解しているため、細菌、真菌等の微生物の栄養源となり
やすい。製紙工程中で細菌・真菌等の微生物がそれら栄
養源を元にして繁殖し、粘液状の代謝産物を産出し、パ
ルプ、填料など製紙工程中に分散している製紙原料を取
り込んで、水流の淀んだチェスト内の壁面やフローボッ
クス等にスライムを形成する。形成されたスライムは、
徐々に増大しやがて離脱しパルプ等の製紙原料と共に紙
に抄き込まれ紙上の異物となってあらわれ、品質の低下
をまねく。また最近では、紙をかなり高速で抄くため、
最悪の場合断紙となり、生産性の低下を引き起こす。
2. Description of the Related Art In the papermaking process in the pulp and paper industry, a large amount of water is used to produce paper, and various organic substances necessary for producing paper are dispersed and dissolved in the water. Therefore, it is likely to be a nutrient source for microorganisms such as bacteria and fungi. During the papermaking process, microorganisms such as bacteria and fungi proliferate based on these nutrient sources, produce slimey metabolites, take in papermaking materials such as pulp and filler that are dispersed in the papermaking process, Slime is formed on the wall or flow box inside the stagnant chest. The formed slime is
It gradually increases and eventually comes off, is made into paper together with papermaking raw materials such as pulp, and appears as foreign matter on the paper, resulting in quality deterioration. Recently, to make paper at a very high speed,
In the worst case, the paper will be cut off, causing a drop in productivity.

【0003】また、塗料、ラテックス、デンプンスラリ
ー液等水をベースに作成されている工業用水系組成物に
ついても、細菌に汚染されることによって腐敗が生じ、
臭気の発生や粘度低下、pH変動等の物性劣化を引き起
こしたり、真菌(糸状菌)が繁殖することによってスト
レーナーの目詰まり、着色、異物混入等を引き起こす。
[0003] In addition, industrial water-based compositions prepared based on water, such as paints, latex, and starch slurries, also become spoiled by being contaminated by bacteria,
Occurrence of odor, deterioration of physical properties such as decrease in viscosity, fluctuation of pH, and the like are caused, and fungus (filamentous fungi) propagates, thereby causing clogging, coloring, and foreign matter mixing of the strainer.

【0004】抄紙工程における微生物要因によるスライ
ムの発生防止するために抗菌剤として各種の薬剤が使用
されてきた。またそれは各種水系組成物の腐敗防止を目
的とした抗菌剤においても同様である。たとえば抄紙工
程においては、殺菌力の非常に強い2,2−ジブロモ−
3−ニトリロプロピオンアミドをはじめ4,5−ジクロ
ロ−1,2−ジチオール−3−オンや静菌力にすぐれた
メチレンビスチオシアネート、1,4−ビス(ブロモア
セトキシ)−2−ブテン又は1,2−ビス(ブロモアセ
トキシ)エタンなどがよく使用されている。水系組成物
の腐敗防止には防腐という性格上、静菌力のすぐれ、水
系組成物中での安定性にすぐれた5−クロロ−2−メチ
ル−4−イソチアゾリン−3−オン、1,2−ベンズイ
ソチアゾリン−3−オン、2,2−ジブロモ−2−ニト
ロエタノール、2−ブロモ−2−ニトロプロパン−1,
3−ジオールなどがよく使用されている。
[0004] Various agents have been used as antibacterial agents to prevent the generation of slime due to microbial factors in the papermaking process. The same applies to antibacterial agents for the purpose of preventing spoilage of various aqueous compositions. For example, in the papermaking process, 2,2-dibromo-
In addition to 3-nitrilopropionamide, 4,5-dichloro-1,2-dithiol-3-one, methylenebisthiocyanate having excellent bacteriostatic power, 1,4-bis (bromoacetoxy) -2-butene or 1,2 -Bis (bromoacetoxy) ethane and the like are often used. To prevent spoilage of the aqueous composition, 5-chloro-2-methyl-4-isothiazolin-3-one, 1,2-, which has excellent bacteriostatic activity and excellent stability in the aqueous composition due to its preservative property. Benzisothiazolin-3-one, 2,2-dibromo-2-nitroethanol, 2-bromo-2-nitropropane-1,
3-diol and the like are often used.

【0005】しかし単一薬剤の長期に渡る連続使用は、
耐性菌の出現を招きやすいため、過去に種々の2成分又
は3成分の組み合わせによる抗菌剤が使用されてきた。
たとえば、2成分の組み合わせには、特公平7−453
66号公報における4,5−ジクロロ−1,2−ジチオ
ール−3−オンと5−クロロ−2−メチル−4−イソチ
アゾリン−3−オンの組み合わせ、特公平1−2012
1号公報における2,2−ジブロモ−3−ニトリロプロ
ピオンアミドと4,5−ジクロロ−1,2−ジチオール
−3−オンの組み合わせなど多数開示されている。3成
分の組み合わせには、特開平7−187920号公報に
おける2,2−ジブロモ−3−ニトリロプロピオンアミ
ドと4,5−ジクロロ−1,2−ジチオール−3−オン
と5−クロロ−2−メチル−4−イソチアゾリン−3−
オンの組み合わせ、特開平7−25708号公報におけ
る2,2−ジブロモ−3−ニトリロプロピオンアミドと
メチレンビスチオシアネートと2,2−ジブロモ−2−
ニトロエタノールの組み合わせなどが開示されている。
これらの組み合わせは単一薬剤が長期にわたって使用さ
れていた製紙工程及び水系組成物に対して良好な効力を
もっているが、2成分、3成分の組み合わせの薬剤が微
生物を制御する手段として一般的になり、組み合わせ配
合でも長期使用による耐性菌が出現し始めてきたため、
さらなる殺菌、静菌効力をもった低濃度で有効な薬剤が
望まれている。
However, the long-term continuous use of a single drug is
Antibacterial agents using various combinations of two or three components have been used in the past because they are likely to cause the emergence of resistant bacteria.
For example, in the combination of two components,
No. 66,4,5-Dichloro-1,2-dithiol-3-one and 5-chloro-2-methyl-4-isothiazolin-3-one,
Many publications disclose a combination of 2,2-dibromo-3-nitrilopropionamide and 4,5-dichloro-1,2-dithiol-3-one in JP-A-1. The combination of the three components includes 2,2-dibromo-3-nitrilopropionamide, 4,5-dichloro-1,2-dithiol-3-one and 5-chloro-2-methyl described in JP-A-7-187920. -4-isothiazoline-3-
Combinations of 2,2-dibromo-3-nitrilopropionamide, methylenebisthiocyanate, and 2,2-dibromo-2- in JP-A-7-25708.
A combination of nitroethanol and the like are disclosed.
While these combinations have good efficacy in papermaking processes and aqueous compositions where a single agent has been used for a long time, two- and three-component agents have become commonplace as a means of controlling microorganisms. , Even in combination formulations, resistant bacteria due to long-term use have begun to appear,
There is a need for a drug that is effective at a low concentration with further bactericidal and bacteriostatic efficacy.

【0006】[0006]

【発明が解決しようとする課題】本発明は、前記のよう
な要望に応えるため、従来の組み合わせでは不充分であ
った強力な殺菌力又は静菌力をもった、広範囲の微生物
に対して有効な薬剤を提供することにある。
SUMMARY OF THE INVENTION In order to meet the above demands, the present invention is effective against a wide range of microorganisms having a strong bactericidal or bacteriostatic power, which was insufficient with conventional combinations. In providing various drugs.

【0007】[0007]

【課題を解決するための手段】本発明者は、課題を解決
するために各種成分の組み合わせにおける効力の確認を
行い、鋭意研究を重ねた結果、ハロシアノアセトアミド
化合物とハロゲン化酢酸エステル誘導体及び4,5−ジ
クロロ−1,2−ジチオール−3−オンの3種の有効成
分を含有することを特徴とする工業用抗菌組成物が低濃
度でも良好な殺菌力、静菌力を併せ持つ非常に優れた抗
菌組成物であることを見いだした。すなわち本発明は
(A)下記一般式 (式中のXはハロゲン原子、Yは水素原子又はハロゲン
原子、Rは水素原子又は低級アルキル基を示す)で表さ
れるハロシアノアセトアミド化合物と(B)下記一般式 (式中のZはハロゲン、Aはアルキレン基又はアルケニ
レン基を示す)で表されるハロゲン化酢酸エステル誘導
体及び(C)4,5−ジクロロ−1,2−ジチオール−
3−オンを含有することを特徴とする工業用抗菌組成物
であり、またこれら3種の有効成分を製紙工程白水又は
工業用水系組成物に1〜20000ppm添加すること
を特徴とする抗菌方法である。
Means for Solving the Problems The present inventor has confirmed the efficacy of combinations of various components in order to solve the problems, and as a result of intensive studies, as a result, it has been found that a halogenated acetoamide compound, a halogenated acetic acid ester derivative and An industrial antibacterial composition characterized by containing three kinds of active ingredients, 5,5-dichloro-1,2-dithiol-3-one, is excellent in having good bactericidal activity and bacteriostatic activity even at a low concentration. Antibacterial composition. That is, the present invention provides (A) the following general formula: (Wherein X represents a halogen atom, Y represents a hydrogen atom or a halogen atom, and R represents a hydrogen atom or a lower alkyl group) and (B) a compound represented by the following general formula: (Wherein Z represents a halogen, A represents an alkylene group or an alkenylene group) and (C) 4,5-dichloro-1,2-dithiol-
An industrial antibacterial composition characterized by containing 3-one, and an antibacterial method characterized by adding 1 to 20,000 ppm of these three active ingredients to papermaking process white water or an industrial aqueous composition. is there.

【発明の実施の形態】BEST MODE FOR CARRYING OUT THE INVENTION

【0008】本発明の(A)成分であるハロシアノアセ
トアミド系化合物としては、たとえば2−クロロ−3−
ニトリロプロピオンアミド、2−ブロモ−3−ニトリロ
プロピオンアミド、2,2−ジクロロ−3−ニトリロプ
ロピオンアミド、2,2−ジブロモ−3−ニトリロプロ
ピオンアミドなどが含まれる。これらは単独で用いても
良いし、2種以上を組み合わせも良い。
The halocyanoacetamide compound as the component (A) of the present invention includes, for example, 2-chloro-3-
Nitrilopropionamide, 2-bromo-3-nitrilopropionamide, 2,2-dichloro-3-nitrilopropionamide, 2,2-dibromo-3-nitrilopropionamide and the like are included. These may be used alone or in combination of two or more.

【0009】本発明の(B)成分であるハロゲン化酢酸
エステル誘導体としては、たとえば1,4−ビス(ブロ
モアセトキシ)−2−ブテン、1,2−ビス(ブロモア
セトキシ)エタン、1,4−ビス(クロロアセトキシ)
−2−ブテンなどが含まれる。
The halogenated acetic acid ester derivatives which are component (B) of the present invention include, for example, 1,4-bis (bromoacetoxy) -2-butene, 1,2-bis (bromoacetoxy) ethane and 1,4-bis (bromoacetoxy) ethane. Bis (chloroacetoxy)
-2-butene and the like.

【0010】(A)ハロシアノアセトアミド化合物は比
較的殺菌効力に優れ、(B)ハロゲン化酢酸エステル誘
導体は比較的静菌効力に優れ、(C)4,5−ジクロロ
−1,2−ジチオール−3−オンは比較的殺菌効力に優
れており、それぞれの有効成分の効果が異なるので、本
発明の3種成分の内1種又は2種の配合量が極端に低い
とその効果が期待できないため成分(A)を1重量部に
対して、成分(B)が0.1〜10重量部好ましくは
0.5〜5重量部で、成分(A)と成分(B)の合計量
を1重量部とした時、成分(C)0.01〜10重量部
好ましくは0.05〜0.5重量部含有させることが望
ましい。また各々の有効成分を混ぜることによる効力の
相乗作用の点からもこの含有割合が望ましい。
(A) The halogenated acetoamide compound is relatively excellent in bactericidal activity, (B) the halogenated acetate derivative is relatively excellent in bacteriostatic activity, and (C) 4,5-dichloro-1,2-dithiol- Since 3-one has relatively excellent bactericidal efficacy and the effect of each active ingredient is different, the effect cannot be expected if the amount of one or two of the three components of the present invention is extremely low. Component (B) is used in an amount of 0.1 to 10 parts by weight, preferably 0.5 to 5 parts by weight, based on 1 part by weight of component (A), and the total amount of component (A) and component (B) is 1 part by weight. Parts (C) is preferably 0.01 to 10 parts by weight, more preferably 0.05 to 0.5 part by weight. This content ratio is also desirable from the viewpoint of the synergistic effect of the effects obtained by mixing the respective active ingredients.

【0011】本発明の有効成分の抄紙工程中又は水系組
成物への添加方法は、各々別々でも、製剤化した混合物
でもよい。添加量は過剰になると物性、外観、品質、コ
スト等に悪影響を及ぼすので1〜20000ppmが好
ましい。
The method of adding the active ingredient of the present invention to the aqueous composition during the papermaking step or to the aqueous composition may be either separately or in the form of a mixture. An excessive amount has an adverse effect on physical properties, appearance, quality, cost, and the like.

【0012】また製剤化に際して用いられる溶媒、界面
活性剤などは特に限定しない。しかし、微生物の増殖を
引き起こす抄紙工程水や水系組成物などの薬剤添加対象
物が水を主とした組成であるため、溶媒は比較的親水性
のものが望ましい。
The solvent, surfactant and the like used in the preparation are not particularly limited. However, since the chemicals to be added such as water in the papermaking process and aqueous compositions that cause the growth of microorganisms are mainly composed of water, the solvent is preferably relatively hydrophilic.

【0013】溶媒としては、エチレングリコール、プロ
ピレングリコール、ジエチレングリコール、トリエチレ
ングリコール、ジプロピレングリコール、ヘキシレング
リコールなどのグリコール系溶剤、ジエチレングリコー
ルモノメチルエーテル、ジエチレングリコールモノエチ
ルエーテル、ジエチレングリコールモノブチルエーテル
などのグリコールエーテル系溶剤やプロピレンカーボネ
ートなどが使用できる。これらは単独で用いても良い
し、2種以上を組み合わせも良く、有効成分の3種を溶
解できる添加量があれば良い。
Examples of the solvent include glycol solvents such as ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol, dipropylene glycol and hexylene glycol, and glycol ether solvents such as diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, and diethylene glycol monobutyl ether. And propylene carbonate. These may be used singly or in combination of two or more kinds, as long as there is an added amount capable of dissolving three kinds of active ingredients.

【0014】界面活性剤としては非イオン系界面活性
剤、陰イオン系界面活性剤、陽イオン系界面活性剤、両
イオン系界面活性剤などが使用できる。
As the surfactant, a nonionic surfactant, an anionic surfactant, a cationic surfactant, a zwitterionic surfactant and the like can be used.

【0015】[0015]

【実施例】次に本発明の実施例および比較例をあげて説
明するが、本発明はこれらに限定されるものではない。
下表に示した配合比率はすべて重量%である。また、各
実施例の抗菌組成物は各実施例に示す各成分をそれぞれ
示す割合で常温において通常の撹拌によって調製した。
EXAMPLES Next, the present invention will be described with reference to examples and comparative examples, but the present invention is not limited to these examples.
All the compounding ratios shown in the following table are% by weight. Further, the antimicrobial compositions of the respective examples were prepared by ordinary stirring at room temperature at the indicated ratios of the respective components shown in the respective examples.

【0016】実施例1〜6 表1に示す抗菌剤組成物を調製し、試験例1、試験例
2、試験例3、試験例4により、その性能を調べた。な
お表中の有効成分の表示は以下の略語にて表す。
Examples 1 to 6 The antibacterial agent compositions shown in Table 1 were prepared, and their performance was examined in Test Example 1, Test Example 2, Test Example 3, and Test Example 4. The indication of the active ingredient in the table is represented by the following abbreviations.

【0017】2,2−ジブロモ−3−ニトリロプロピオ
ンアミド:DBNPA(A成分) 1,4−ビス(ブロモアセトキシ)−2−ブテン :B
BAB(B成分) 4,5−ジクロロ−1,2−ジチオール−3−オン:D
CDT(C成分)
2,2-dibromo-3-nitrilopropionamide: DBNPA (component A) 1,4-bis (bromoacetoxy) -2-butene: B
BAB (Component B) 4,5-dichloro-1,2-dithiol-3-one: D
CDT (C component)

【0018】[0018]

【表1】 [Table 1]

【0019】比較例1〜4 表2に示す抗菌剤組成物を調製し、試験例1、試験例
2、試験例3により、その性能を調べた。
Comparative Examples 1 to 4 The antibacterial agent compositions shown in Table 2 were prepared, and their performances were examined in Test Examples 1, 2, and 3.

【0020】[0020]

【表2】 [Table 2]

【0021】試験例1 製紙工程白水に対する殺菌力評
価 「試験方法」実施例及び比較例の製剤品を所定濃度添加
した下記対象試料を培養し、菌数の経時変化を変性ワッ
クスマン寒天平板混釈法(試料を滅菌水で希釈し、この
一定量を滅菌シャーレにとり、溶解した変性ワックスマ
ン寒天培地を注入し、混釈した後固化させる。30℃の
恒温室内で2日間培養後形成されたコロニー数をカウン
トする。)にて測定した。 対象試料:某製紙会社製紙工程白水、上質紙抄造、pH
7.4、 生菌数9.6×106CFU/ml 「試験結果」各製剤品を添加後30分、60分後の菌数
値を測定し、薬剤無添加試料の菌数値と製剤品添加試料
の菌数値の増減値差を表3に示した。 増減値差:所定時間後の薬剤無添加試料の菌数の対数値
製剤品添加試料の菌数の対数値 値が大きい
方が殺菌効力が大きい。 表3に示したように比較例1〜3の単独の有効成分の製
剤品、比較例4〜6の2種の有効成分の製剤品の増減値
差に比べて、実施例1〜3の3種の有効成分の製剤品の
増減値差は明らかに大きい値を示し、有効成分各々単独
又は2種混合の製剤品に比べて3種混合の製剤品は製紙
工程白水に対して顕著な殺菌力を示すことが確認され
た。
Test Example 1 Evaluation of bactericidal activity against white water in the papermaking process Test Method The following target samples to which the preparations of Examples and Comparative Examples were added at a predetermined concentration were cultured, and the time-dependent change in the number of bacteria was examined by denaturation with modified waxman agar plate. Method (Dilute the sample with sterile water, take a certain amount of this in a sterile petri dish, inject the dissolved denatured Waxman agar medium, allow to pour, and solidify. The number is counted.). Target sample: papermaking process white water, high quality paper making, pH of a certain paper company
7.4, viable cell count 9.6 × 10 6 CFU / ml “Test result” The bacterial value was measured 30 minutes and 60 minutes after the addition of each formulation, and the bacterial value of the drug-free sample and the formulation added Table 3 shows the difference between the increase and decrease in the bacterial value of the sample. Difference in increase / decrease value: The larger the logarithmic value of the number of bacteria of the sample without drug after a predetermined time−the value of the logarithm of the number of bacteria of the sample added with the pharmaceutical product, the larger the bactericidal effect. As shown in Table 3, as compared with the increase / decrease value difference of the preparations of the single active ingredients of Comparative Examples 1 to 3 and the preparations of the two active ingredients of Comparative Examples 4 to 6, The difference in the increase / decrease value of the preparations of the various active ingredients shows a clearly large value, and the preparation of the three kinds of the active ingredients has a remarkable bactericidal activity against white water in the papermaking process as compared with the preparation of the single kind or the mixture of the two kinds. Was confirmed.

【0022】[0022]

【表3】 [Table 3]

【0023】試験例2 製紙工程白水に対する静菌力評
価「試験方法」実施例及び比較例の製剤品を下記対象試
料を無菌濾過したものに所定濃度添加後、10倍濃度変
性ワックスマン液体培地を1%添加、対象試料を接種用
としてそのまま1%添加した。比濁法による濁度の変化
を経時的に記録した微生物増殖曲線によって、静菌力を
測定した。 対象試料:某製紙会社製紙工程白水、上質紙抄造、pH
7.2、 生菌数8.9×106 CFU/ml 「試験結果」薬剤無添加試料の微生物増殖曲線の立ち上
がり時間と各製剤品添加試料の微生物増殖曲線の立ち上
がり時間との差を表4に示した。 差:各製剤品添加試料の立ち上がり時間薬剤無添加試
料の立ち上がり時間 差の値が大きい程、静菌効力が大きい。 表4に示したように比較例1〜3の単独の有効成分の製
剤品、比較例4〜6の2種の有効成分の製剤品の薬剤無
添加試料との立ち上がり時間の差に比べて、実施例1〜
3の3種の有効成分の製剤品の立ち上がり時間の差は明
らかに大きい値を示し、有効成分各々単独又は2種混合
の製剤品に比べて3種混合の製剤品は製紙工程白水に対
して顕著な静菌力を示すことが確認された。
Test Example 2 Evaluation of Bacteriostatic Activity against White Water in the Paper Making Process "Test Method" The following preparations were subjected to aseptic filtration of the preparations of Examples and Comparative Examples to a predetermined concentration, and then a 10-fold concentration of a modified waxman liquid medium was added. 1% was added, and 1% of the target sample was added as it was for inoculation. The bacteriostatic power was measured by a microbial growth curve in which the change in turbidity by the turbidimetry was recorded with time. Target sample: papermaking process white water, high quality paper making, pH of a certain paper company
7.2, viable cell count 8.9 × 10 6 CFU / ml “Test results” Table 4 shows the difference between the rise time of the microbial growth curve of the sample without the drug and the rise time of the microbial growth curve of the sample with each preparation added. It was shown to. Difference: rise time of each drug product-added sample- drug-free test
The greater the value of the difference between the rise times of the ingredients, the greater the bacteriostatic efficacy. As shown in Table 4, compared with the difference between the rise times of the preparations of the single active ingredients of Comparative Examples 1 to 3 and the drug-free sample of the preparations of the two active ingredients of Comparative Examples 4 to 6, Example 1
The difference between the rise times of the preparations of the three active ingredients of No. 3 shows a clearly large value. It was confirmed that it exhibited remarkable bacteriostatic power.

【0024】[0024]

【表4】 [Table 4]

【0025】試験例3 デンプンスラリーの防腐評価 「試験方法」某社カチオン化タピオカデンプンの10%
スラリー(pH6.2)を調製し、滅菌ポリプロピレン
瓶に30g分注し薬剤を所定量添加した後、あらかじめ
腐敗させたデンプンスラリー(菌数:3.2×107
を1%接種した。これを密閉静置条件で30℃で培養
し、TGC寒天平板混釈法によって経時的な生菌数を測
定し、防腐効果を判定した。また、生菌数測定後、腐敗
品を1週間毎に、1%接種した。 「試験結果」下記の判定基準をもって判定し、試験結果
を表5に示した。 表5に示したように比較例1〜3の単独の有効成分の製
剤品、比較例4〜6の2種の有効成分の製剤品の28日
目の評価結果は+++ 〜++++であるのに対して、実施例1
〜3の3種の有効成分の評価結果は+〜++で、有効成分
各々単独又は2種混合の製剤品に比べて3種混合の製剤
品はデンプンスラリーに対して顕著な防腐効力を示すこ
とが確認された。
Test Example 3 Antiseptic Evaluation of Starch Slurry "Test Method" 10% of Cationized Tapioca Starch
A slurry (pH 6.2) was prepared, 30 g was dispensed into a sterilized polypropylene bottle, a predetermined amount of a drug was added, and then a starch slurry that had been spoiled in advance (the number of bacteria: 3.2 × 10 7 )
Was inoculated at 1%. This was cultured at 30 ° C. in a closed and stationary condition, and the viable cell count over time was measured by TGC agar plate pour method to determine the preservative effect. After the viable cell count, 1% of the spoiled product was inoculated weekly. "Test results" The test results were determined according to the following criteria, and the test results are shown in Table 5. As shown in Table 5, the evaluation results on the 28th day of the preparations of the single active ingredients of Comparative Examples 1 to 3 and the preparations of the two active ingredients of Comparative Examples 4 to 6 were +++ to +++. Example 1 in contrast to +
The evaluation results of the three kinds of active ingredients of ~ 3 are + ~ ++, and the preparations of the three kinds of the active ingredients show a remarkable antiseptic effect on the starch slurry as compared with the preparations of the single kind or the mixture of the two kinds respectively. It was confirmed that.

【0026】[0026]

【表5】 [Table 5]

【0027】[0027]

【発明の効果】以上のように本発明を適用した場合、従
来の単独又は2種混合の組み合わせでは不充分であった
強力な殺菌力、長時間にわたる静菌力、長期間にわたる
防腐効力を合わせ持った抗菌組成物または抗菌方法の提
供が可能である。
As described above, when the present invention is applied, a strong bactericidal power, a long-lasting bacteriostatic power, and a long-term antiseptic effect, which were insufficient with the conventional single or combination of two kinds, are combined. It is possible to provide an antimicrobial composition or an antimicrobial method having the same.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】(A)一般式 (式中のXはハロゲン原子、Yは水素原子又はハロゲン
原子、Rは水素原子又は低級アルキル基を示す)で表さ
れるハロシアノアセトアミド化合物、 (B)一般式 (式中のZはハロゲン、Aはアルキレン基又はアルケニ
レン基を示す)で表されるハロゲン化酢酸エステル誘導
体及び(C)4,5−ジクロロ−1,2−ジチオール−
3−オンを含有することを特徴とする工業用抗菌組成
物。
(1) General formula (A) (Wherein X is a halogen atom, Y is a hydrogen atom or a halogen atom, and R is a hydrogen atom or a lower alkyl group), (B) a general formula (Wherein Z represents a halogen, A represents an alkylene group or an alkenylene group) and (C) 4,5-dichloro-1,2-dithiol-
An industrial antibacterial composition comprising 3-one.
【請求項2】 成分(A)を1重量部に対して、成分
(B)が0.1〜10重量部好ましくは0.5〜5重量
部で、成分(A)と成分(B)の合計量を1重量部とし
た時、成分(C)0.01〜10重量部好ましくは0.
05〜0.5重量部を含む請求項1記載の工業用抗菌組
成物。
2. Component (A) is used in an amount of 0.1 to 10 parts by weight, preferably 0.5 to 5 parts by weight, based on 1 part by weight of component (A). When the total amount is 1 part by weight, component (C) is 0.01 to 10 parts by weight, preferably 0.1 to 10 parts by weight.
The industrial antibacterial composition according to claim 1, comprising from 0.5 to 0.5 parts by weight.
【請求項3】 成分(A)が2,2−ジブロモ−3−ニ
トリロプロピオンアミド、成分(B)が1,4−ビス
(ブロモアセトキシ)−2−ブテン又は1,2−ビス
(ブロモアセトキシ)エタンである請求項1記載の工業
用抗菌組成物。
3. Component (A) is 2,2-dibromo-3-nitrilopropionamide, and component (B) is 1,4-bis (bromoacetoxy) -2-butene or 1,2-bis (bromoacetoxy). The industrial antibacterial composition according to claim 1, which is ethane.
【請求項4】 請求項1記載の工業用抗菌組成物を製紙
工程白水又は工業用水系組成物に1〜20000ppm
添加することを特徴とする抗菌方法。
4. An industrial antibacterial composition according to claim 1, which is added to the papermaking process white water or industrial aqueous composition in an amount of 1 to 20,000 ppm.
An antimicrobial method characterized by being added.
JP9121608A 1997-04-23 1997-04-23 Sterilization composition for industry and sterilization Pending JPH10298006A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9121608A JPH10298006A (en) 1997-04-23 1997-04-23 Sterilization composition for industry and sterilization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9121608A JPH10298006A (en) 1997-04-23 1997-04-23 Sterilization composition for industry and sterilization

Publications (1)

Publication Number Publication Date
JPH10298006A true JPH10298006A (en) 1998-11-10

Family

ID=14815474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9121608A Pending JPH10298006A (en) 1997-04-23 1997-04-23 Sterilization composition for industry and sterilization

Country Status (1)

Country Link
JP (1) JPH10298006A (en)

Similar Documents

Publication Publication Date Title
JP4141542B2 (en) Industrial disinfectant and disinfecting method using the same
JPH10298006A (en) Sterilization composition for industry and sterilization
JP4136048B2 (en) Industrial antimicrobial composition and antimicrobial method
JPH11222405A (en) Antimicrobial composition for industrial use and antimicrobial treatment
JP4726333B2 (en) Industrial antibacterial composition and antibacterial method
JP2959970B2 (en) Industrial disinfectant and industrial disinfection method
JP2000080002A (en) Antimicrobial composition for industrial purpose and antimicrobial method
US5017592A (en) Stable biocide composition for industrial use
JP4141018B2 (en) Industrial antibacterial agent composition and antibacterial method
JP3754987B2 (en) Industrial sterilization / bacteriostatic agent and industrial sterilization / bacteriostatic method
JP4149045B2 (en) Industrial antibacterial agent composition and antibacterial method
JP2000063211A (en) Industrial antimicrobial agent composition and antimicrobial method
JPH01221302A (en) Bactericide for industry and sterilization
JPH08231320A (en) Industrial germicide and method for industrial sterilization
JP3848970B2 (en) Industrial disinfectant / bacteriostatic agent and industrial disinfectant / bacteriostatic method
JP2891629B2 (en) Industrial bactericidal and bacteriostatic agents
JP4201885B2 (en) Harmful microorganism eradication agent
JPH05105604A (en) Germicidal, algicidal and antiseptic agent for industry
JP2000063212A (en) Industrial antimicrobial agent composition and antimicrobial method
JPH1017413A (en) Exterminating agent for harmful microorganism and extermination of harmful microorganism in white water system using the same
JP2664480B2 (en) Industrial disinfecting / bacteriostatic agents and disinfecting / bacteriostatic methods
JP2851347B2 (en) Industrial bactericidal and bacteriostatic agents
JP3252015B2 (en) Industrial germicidal composition
JP2697977B2 (en) Industrial fungicides
JPH072606A (en) Fungicidal, antiseptic and algaecidal agents for industrial purposes